{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T21:14:02Z","timestamp":1762982042062,"version":"3.37.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Sichuan Vocational College of Health and Rehabilitation","award":["CWKY-2022Z-04"],"award-info":[{"award-number":["CWKY-2022Z-04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-02652-7","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T10:52:13Z","timestamp":1739789533000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Genotypic analysis of human papillomavirus in cervical exfoliated cells from women in Zigong"],"prefix":"10.1186","volume":"22","author":[{"given":"Xiaoyang","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixing","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,17]]},"reference":[{"issue":"3","key":"2652_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"issue":"10167","key":"2652_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","volume":"393","author":"PA Cohen","year":"2019","unstructured":"Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019;393(10167):169\u2013. https:\/\/doi.org\/10.1016\/S0140-6736(18)32470-X. \u200982.","journal-title":"Lancet"},{"issue":"2","key":"2652_CR3","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","volume":"8","author":"M Arbyn","year":"2020","unstructured":"Arbyn M, Weiderpass E, Bruni L, de Sanjos\u00e9 S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Global Health. 2020;8(2):e191\u2013203. https:\/\/doi.org\/10.1016\/S2214-109X(19)30482-6.","journal-title":"Lancet Global Health"},{"key":"2652_CR4","doi-asserted-by":"publisher","unstructured":"Williamson A-L. Recent developments in human papillomavirus (HPV) vaccinology. Viruses. 2023;15(7):1440. https:\/\/doi.org\/10.3390\/v15071440","DOI":"10.3390\/v15071440"},{"issue":"10451","key":"2652_CR5","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0140-6736(24)01097-3","volume":"404","author":"F Wei","year":"2024","unstructured":"Wei F, Georges D, Man I, Baussano I, Clifford GM. Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature. Lancet. 2024;404(10451):435\u201344. https:\/\/doi.org\/10.1016\/S0140-6736(24)01097-3.","journal-title":"Lancet"},{"issue":"10451","key":"2652_CR6","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S0140-6736(24)01547-2","volume":"404","author":"M Schiffman","year":"2024","unstructured":"Schiffman M, de Sanjose S. The rational design of cervical cancer prevention strategies. Lancet. 2024;404(10451):406\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(24)01547-2.","journal-title":"Lancet"},{"key":"2652_CR7","unstructured":"Cancer IAfRo. IARC monographs on the evaluation of carcinogenic risks to humans. WHO; 2012. p. 499."},{"key":"2652_CR8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.canlet.2019.11.039","volume":"471","author":"R Wang","year":"2020","unstructured":"Wang R, Pan W, Jin L, Huang W, Li Y, Wu D, et al. Human papillomavirus vaccine against cervical cancer: opportunity and challenge. Cancer Lett. 2020;471:88\u2013102. https:\/\/doi.org\/10.1016\/j.canlet.2019.11.039.","journal-title":"Cancer Lett"},{"issue":"1","key":"2652_CR9","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12985-024-02447-2","volume":"21","author":"J-P Hu","year":"2024","unstructured":"Hu J-P, Wang J-L, Li Y, Feng Y, Tian C-Q, Zhang G-H, et al. Prevalence and genotype distribution of human papillomavirus infection among 66000 women from 2014 to 2023 in the plateau region of Southwest China. Virol J. 2024;21(1):176. https:\/\/doi.org\/10.1186\/s12985-024-02447-2.","journal-title":"Virol J"},{"key":"2652_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.mrrev.2016.07.002","volume":"772","author":"ME Harden","year":"2017","unstructured":"Harden ME, Munger K. Human papillomavirus molecular biology. Mutat Research\/Reviews Mutat Res. 2017;772:3\u201312. https:\/\/doi.org\/10.1016\/j.mrrev.2016.07.002.","journal-title":"Mutat Research\/Reviews Mutat Res"},{"issue":"4","key":"2652_CR11","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.jiph.2023.02.014","volume":"16","author":"AAA Oyouni","year":"2023","unstructured":"Oyouni AAA. Human papillomavirus in cancer: infection, disease transmission, and progress in vaccines. J Infect Public Health. 2023;16(4):626\u2013. https:\/\/doi.org\/10.1016\/j.jiph.2023.02.014. \u200931.","journal-title":"J Infect Public Health"},{"issue":"20","key":"2652_CR12","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1056\/NEJMsr2030640","volume":"385","author":"V Bouvard","year":"2021","unstructured":"Bouvard V, Wentzensen N, Mackie A, Berkhof J, Brotherton J, Giorgi-Rossi P, et al. The IARC perspective on cervical cancer screening. N Engl J Med. 2021;385(20):1908\u201318. https:\/\/doi.org\/10.1056\/NEJMsr2030640.","journal-title":"N Engl J Med"},{"key":"2652_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-021-02026-0","volume":"19","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Bao H, Ma L, Song B, Di J, Wang L, et al. Real-world effectiveness of primary screening with high-risk human papillomavirus testing in the cervical cancer screening programme in China: a nationwide, population-based study. BMC Med. 2021;19:1\u201311. https:\/\/doi.org\/10.1186\/s12916-021-02026-0.","journal-title":"BMC Med"},{"issue":"2","key":"2652_CR14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","volume":"24","author":"RB Perkins","year":"2020","unstructured":"Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, et al. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2020;24(2):102\u201331. https:\/\/doi.org\/10.1097\/LGT.0000000000000525.","journal-title":"J Low Genit Tract Dis"},{"key":"2652_CR15","volume-title":"WHO Guideline for Screening and Treatment of cervical pre-cancer lesions for Cervical Cancer Prevention, second edition: web annex A: syntheses of evidence","author":"WHO","year":"2021","unstructured":"WHO. WHO Guideline for Screening and Treatment of cervical pre-cancer lesions for Cervical Cancer Prevention, second edition: web annex A: syntheses of evidence. Switzerland: World Health Organization; 2021."},{"key":"2652_CR16","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1016\/S0264-410X(07)01183-8","volume":"25","author":"X Castellsague","year":"2007","unstructured":"Castellsague X, de Sanjos\u00e9 S, Aguado T, Louie KS, Bruni L, Mu\u00f1oz J, et al. HPV and cervical cancer in the 2007 report. Vaccine. 2007;25:C1.","journal-title":"Vaccine"},{"issue":"1","key":"2652_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12985-021-01732-8","volume":"19","author":"X Wang","year":"2022","unstructured":"Wang X, Song Y, Wei X, Wang G, Sun R, Wang M, et al. Prevalence and distribution of human papillomavirus genotypes among women attending gynecology clinics in northern Henan Province of China. Virol J. 2022;19(1):6. https:\/\/doi.org\/10.1186\/s12985-021-01732-8.","journal-title":"Virol J"},{"issue":"1","key":"2652_CR18","doi-asserted-by":"publisher","first-page":"e2176009","DOI":"10.1080\/22221751.2023.2176009","volume":"12","author":"X Yang","year":"2023","unstructured":"Yang X, Li Y, Tang Y, Li Z, Wang S, Luo X, et al. Cervical HPV infection in Guangzhou, China: an epidemiological study of 198,111 women from 2015 to 2021. Emerg Microbes Infections. 2023;12(1):e2176009. https:\/\/doi.org\/10.1080\/22221751.2023.2176009.","journal-title":"Emerg Microbes Infections"},{"key":"2652_CR19","doi-asserted-by":"publisher","first-page":"102372","DOI":"10.1016\/j.canep.2023.102372","volume":"84","author":"Y Ruan","year":"2023","unstructured":"Ruan Y, Li H, Liu M, Cao G, Xu X, Han L, et al. A retrospective analysis of human papillomavirus (HPV) prevalence and genotype distribution among 25,238 women in Shanghai, China revealed the limitations of current HPV-based screening and HPV vaccine. Cancer Epidemiol. 2023;84:102372. https:\/\/doi.org\/10.1016\/j.canep.2023.102372.","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"2652_CR20","doi-asserted-by":"publisher","first-page":"e0210311","DOI":"10.1371\/journal.pone.0210311","volume":"14","author":"L Jiang","year":"2019","unstructured":"Jiang L, Tian X, Peng D, Zhang L, Xie F, Bi C, et al. HPV prevalence and genotype distribution among women in Shandong Province, China: analysis of 94,489 HPV genotyping results from Shandong\u2019s largest independent pathology laboratory. PLoS ONE. 2019;14(1):e0210311. https:\/\/doi.org\/10.1371\/journal.pone.0210311.","journal-title":"PLoS ONE"},{"issue":"4","key":"2652_CR21","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1080\/21645515.2020.1805993","volume":"17","author":"Q Mai","year":"2021","unstructured":"Mai Q, Yang X, Cheng H, Wu G, Wu Z. Prevalence and genotype distribution of human papillomavirus among women with cervical lesions in Shenzhen city. China Hum Vaccines Immunotherapeutics. 2021;17(4):965\u201371. https:\/\/doi.org\/10.1080\/21645515.2020.1805993.","journal-title":"China Hum Vaccines Immunotherapeutics"},{"key":"2652_CR22","doi-asserted-by":"publisher","first-page":"710209","DOI":"10.3389\/fpubh.2021.710209","volume":"9","author":"S-y Tang","year":"2021","unstructured":"Tang S-y, Liao Y-q, Hu Y, Shen H-y, Wan Y-p, Wu Y-m. HPV prevalence and genotype distribution among women from Hengyang district of Hunan Province, China. Front Public Health. 2021;9:710209. https:\/\/doi.org\/10.3389\/fpubh.2021.710209.","journal-title":"Front Public Health"},{"issue":"1","key":"2652_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13027-022-00431-5","volume":"17","author":"L Wei","year":"2022","unstructured":"Wei L, Ma L, Qin L, Huang Z. The prevalence and genotype distribution of human papillomavirus among women in Guangxi, southern China. Infect Agent Cancer. 2022;17(1):19. https:\/\/doi.org\/10.1186\/s13027-022-00431-5.","journal-title":"Infect Agent Cancer"},{"issue":"1","key":"2652_CR24","doi-asserted-by":"publisher","first-page":"2212571","DOI":"10.1080\/21645515.2023.2212571","volume":"19","author":"Y Ma","year":"2023","unstructured":"Ma Y, Xia X, Zheng W, Dai Y, Zhuang X. HPV prevalence and genotype distribution among women in eastern China during the Covid-19 pandemic. Hum Vaccines Immunotherapeutics. 2023;19(1):2212571. https:\/\/doi.org\/10.1080\/21645515.2023.2212571.","journal-title":"Hum Vaccines Immunotherapeutics"},{"issue":"11","key":"2652_CR25","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/S1470-2045(21)00453-8","volume":"22","author":"P Basu","year":"2021","unstructured":"Basu P, Malvi SG, Joshi S, Bhatla N, Muwonge R, Lucas E, et al. Vaccine efficacy against persistent human papillomavirus (HPV) 16\/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study. Lancet Oncol. 2021;22(11):1518\u201329. https:\/\/doi.org\/10.1016\/S1470-2045(21)00453-8.","journal-title":"Lancet Oncol"},{"key":"2652_CR26","doi-asserted-by":"publisher","unstructured":"Shiqing L, Zewei C, Xiaoli Y, Jing L, Jiahui Z, Xiangdong G. Epidemic trends and spatiotemporal distribution characteristics of condyloma acuminatum in China from 2018 to 2023. Chin J Epidemiol.45(8):1073\u20138https:\/\/doi.org\/10.3760\/cma.j.cn112338-20240308-00107","DOI":"10.3760\/cma.j.cn112338-20240308-00107"},{"issue":"1","key":"2652_CR27","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.virusres.2011.09.032","volume":"163","author":"V Cento","year":"2012","unstructured":"Cento V, Rahmatalla N, Ciccozzi M, Presti AL, Perno CF, Ciotti M. Human papillomaviruses 53 and 66: clinical aspects and genetic analysis. Virus Res. 2012;163(1):212\u201322. https:\/\/doi.org\/10.1016\/j.virusres.2011.09.032.","journal-title":"Virus Res"},{"key":"2652_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-021-06853-7","volume":"21","author":"R Chen","year":"2021","unstructured":"Chen R, Fu Y, You B, Li Y, Yao Y, Wang X, et al. Clinical characteristics of single human papillomavirus 53 infection: a retrospective study of 419 cases. BMC Infect Dis. 2021;21:1\u20137. https:\/\/doi.org\/10.1186\/s12879-021-06853-7.","journal-title":"BMC Infect Dis"},{"key":"2652_CR29","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1007\/s00705-020-04771-8","volume":"165","author":"K Ju\u00e1rez-Gonz\u00e1lez","year":"2020","unstructured":"Ju\u00e1rez-Gonz\u00e1lez K, Paredes-Cervantes V, Gordillo-Rodr\u00edguez S, Gonzalez-Guzman S, Moncayo-Valencia X, M\u00e9ndez-Mart\u00ednez R, et al. High prevalence of human papillomavirus type 66 in low-grade cervical lesions of Mexican women. Arch Virol. 2020;165:2633\u201340. https:\/\/doi.org\/10.1007\/s00705-020-04771-8.","journal-title":"Arch Virol"},{"key":"2652_CR30","doi-asserted-by":"publisher","first-page":"102360","DOI":"10.1016\/j.canep.2023.102360","volume":"84","author":"N Li","year":"2023","unstructured":"Li N, Cheng C, Liang R, Zhu Q, Xue F, Xu L, et al. Epidemiological analysis of HPV in Sichuan during 2014\u20132021. Cancer Epidemiol. 2023;84:102360. https:\/\/doi.org\/10.1016\/j.canep.2023.102360.","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"2652_CR31","doi-asserted-by":"publisher","first-page":"14813","DOI":"10.1038\/s41598-017-13299-y","volume":"7","author":"X Chen","year":"2017","unstructured":"Chen X, Xu H, Xu W, Zeng W, Liu J, Wu Q, et al. Prevalence and genotype distribution of human papillomavirus in 961,029 screening tests in southeastern China (Zhejiang Province) between 2011 and 2015. Sci Rep. 2017;7(1):14813. https:\/\/doi.org\/10.1038\/s41598-017-13299-y.","journal-title":"Sci Rep"},{"issue":"8","key":"2652_CR32","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1002\/jmv.27013","volume":"93","author":"X Zhu","year":"2021","unstructured":"Zhu X, Wang Y, Lv Z, Su J. Prevalence and genotype distribution of high-risk HPV infection among women in Beijing, China. J Med Virol. 2021;93(8):5103\u20139. https:\/\/doi.org\/10.1002\/jmv.27013.","journal-title":"J Med Virol"},{"issue":"9895","key":"2652_CR33","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","volume":"382","author":"EJ Crosbie","year":"2013","unstructured":"Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC. Human papillomavirus and cervical cancer. Lancet. 2013;382(9895):889\u2013. https:\/\/doi.org\/10.1016\/S0140-6736(13)60022-7. \u200999.","journal-title":"Lancet"},{"issue":"1","key":"2652_CR34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.19538\/j.fk2018010111","volume":"34","author":"L Ping","year":"2018","unstructured":"Ping L. Evaluation of 13 years of clinical epidemiological Big Data on Cervical Cancer in Mainland China. Chin J Practical Gynecol Obstet. 2018;34(1):41\u20135. https:\/\/doi.org\/10.19538\/j.fk2018010111.","journal-title":"Chin J Practical Gynecol Obstet"},{"issue":"4","key":"2652_CR35","doi-asserted-by":"publisher","first-page":"335","DOI":"10.5468\/ogs.22025","volume":"65","author":"N Jareemit","year":"2022","unstructured":"Jareemit N, Horthongkham N, Therasakvichya S, Viriyapak B, Inthasorn P, Benjapibal M, et al. Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesion cytology, and its immediate risk for high-grade cervical lesion or cancer: a single-center, cross-sectional study. Obstet Gynecol Sci. 2022;65(4):335\u201345. https:\/\/doi.org\/10.5468\/ogs.22025.","journal-title":"Obstet Gynecol Sci"},{"issue":"5","key":"2652_CR36","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3760\/cma.j.issn.0412-4030.2017.05.003","volume":"50","author":"Y Xiaoli","year":"2017","unstructured":"Xiaoli Y, Xiangdong G, Jing L, Fei T, Ning J, Peixuan M, et al. Epidemiological features of condyloma acuminatum in national sexually transmitted disease surveillance sites in China from 2008 to 2016. Chin J Dermatology. 2017;50(5):321\u20135. https:\/\/doi.org\/10.3760\/cma.j.issn.0412-4030.2017.05.003.","journal-title":"Chin J Dermatology"},{"issue":"7","key":"2652_CR37","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.3390\/v13071342","volume":"13","author":"M Kim","year":"2021","unstructured":"Kim M, Park NJ-Y, Jeong JY, Park JY. Multiple human papilloma virus (HPV) infections are associated with HSIL and persistent HPV infection status in Korean patients. Viruses. 2021;13(7):1342. https:\/\/doi.org\/10.3390\/v13071342.","journal-title":"Viruses"},{"issue":"2","key":"2652_CR38","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/cncy.21789","volume":"125","author":"L De Brot","year":"2017","unstructured":"De Brot L, Pellegrini B, Moretti ST, Carraro DM, Soares FA, Rocha RM, et al. Infections with multiple high-risk HPV types are associated with high\u2010grade and persistent low\u2010grade intraepithelial lesions of the cervix. Cancer Cytopathol. 2017;125(2):138\u201343. https:\/\/doi.org\/10.1002\/cncy.21789.","journal-title":"Cancer Cytopathol"},{"issue":"1","key":"2652_CR39","doi-asserted-by":"publisher","first-page":"2334474","DOI":"10.1080\/21645515.2024.2334474","volume":"20","author":"Y Su","year":"2024","unstructured":"Su Y, Zheng T, Bi Z, Jia X, Li Y, Kuang X, et al. Pattern of multiple human papillomavirus infection and type competition: an analysis in healthy Chinese women aged 18\u201345 years. Hum Vaccines Immunotherapeutics. 2024;20(1):2334474. https:\/\/doi.org\/10.1080\/21645515.2024.2334474.","journal-title":"Hum Vaccines Immunotherapeutics"},{"issue":"5","key":"2652_CR40","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1128\/jcm.00087-13","volume":"51","author":"M Schmitt","year":"2013","unstructured":"Schmitt M, Depuydt C, Benoy I, Bogers J, Antoine J, Arbyn M, et al. Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities. J Clin Microbiol. 2013;51(5):1458\u201364. https:\/\/doi.org\/10.1128\/jcm.00087-13.","journal-title":"J Clin Microbiol"},{"key":"2652_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/10732748241257902","volume":"31","author":"Y Gao","year":"2024","unstructured":"Gao Y, Zhang M, Zheng Y, Huang H, Xie H. Human papilloma virus infection and Gene Subtypes Analysis in women undergoing physical examinations: a 2015\u20132020 study in Wenzhou, China. Cancer Control. 2024;31:1\u20139. https:\/\/doi.org\/10.1177\/10732748241257902.","journal-title":"Cancer Control"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02652-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02652-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02652-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T10:52:23Z","timestamp":1739789543000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02652-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2652"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02652-7","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,17]]},"assertion":[{"value":"12 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study process was approved by the Medical Research Ethics Committee in Zigong Fourth People\u2019s Hospital. All patients are completely anonymous and free from any personal privacy.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors agree to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}